🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New systematic review and meta-analysis in The Lancet Gastroenterology & Hepatology demonstrates that response to DAA #HCV therapy is favourable in people with recent drug use and those receiving #OST - Great leadership by Behzad Hajari Kirby Institute, UNSW - #INHSU18 INHSU thelancet.com/journals/langa…

New: Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis - thelancet.com/journals/langa… #nohep #hepC #free for #INHSU18 INHSU Jason Grebely Behzad Hajari

Monitoring #HCV adherence using a novel electronic blister pack among recent #PWID receiving #DAA therapy with SOF/VEL in the SIMPLIFY study - great presentation by Evan Cunningham Kirby Institute, UNSW #INHSU18 INHSU

.Evan Cunningham from Kirby Institute, UNSW presenting data which help to understand adherence to #HCV DAA therapy in #PWID in the SIMPLIFY study at #INHSU18 INHSU

"We need to stop viral hepatitis and its stigma from ravaging the lives of millions of people" Professor Manal El-Sayed has sent a powerful #WHDRelay message from Cairo, Egypt. Thank you, Manal! Watch her video below and let us know what your #WorldHepatitisDay message is.

See the opinion piece authored by myself and @LanieceDelaunay and all of the CanHepCTrainees published today in the Montreal Gazette! Let's all work together and commit to #hepatitisC elimination in the era of COVID-19! CanHepC Network Kirby Institute, UNSW

Check out our CanHepCTrainees opinion peice in the Montreal Gazette today on the impact of COVID-19 on the battle against hepatitis C @LanieceDelaunay World Hepatitis Alliance #WHD2020 montrealgazette.com/opinion/opinio…

#CanHepC investigator Dr Curtis Cooper on the impact of covid-19 on hepatitis C services and challenges ahead as we strive for elimination: CATIE #WorldHepatitisDay thesudburystar.com/news/local-new…

Very proud to announce that Coalition for Global Hepatitis Elimination has named Dr Brian Conway a 2020 Elimination Champion!🏆 He's among 5 other champions selected across the🌎for his commitment to making #HCV elimination benefit all of society, including the most vulnerable. ⬇️ globalhep.org/elimination-ch…

Congrats to CanHepC lead researcher Dr Mel Krajden who will be receiving BC's highest honor🎖️for his outstanding work advancing public health policies for #Hepatitis and other viruses! We already knew he was an increadible human being, now it's official! Well deserved! 👏👏

Proud to be leading this $6.5M Australian Dept of Health, Disability and Ageing grant to scale-up point-of-care Xpert HCV RNA testing in Australia. This game-changing test enables same-visit HCV diagnosis and treatment, facilitating elimination efforts. Thanks to >30 partners, including Flinders University Hepatitis Australia.

Pleased to share our International Journal of Drug Policy editorial highlighting the need for person-centred strategies to address HCV, other infectious diseases, and harms that may relate to drug use. Highlights a special issue with nearly 40 papers on these topics sciencedirect.com/science/articl…

Do you want to hear about exciting career trajectories? Join Dr Suzi Hudson, Daniel Wolfe, Stuart Manoj-Margison and Shelley Facente, PhD, MPH this Friday morning at the #INHSU2021 conference to discuss how you can build on your research experience to meet your career goals.

PhD candidate @valerio_heather will be presenting at today's Progress Toward HCV Elimination parallel session at #INHSU21. Come hear about the progress toward HCV elimination in Australia and where we need to concentrate our efforts to ensure this elimination is equitable.

Dr Alison Marshall's presentation on the willingness among people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate HCV treatment is available on-demand at #INHSU21. Grab your cup of INHSU coffee and give it a watch!

Evan Cunningham from Kirby Institute, UNSW, covering ‘Interventions to Enhance Testing and Treatment Uptake for Hepatitis C Infection’. This systematic review is part of the evidence underpinning INHSU’s exciting HCV Intervention Toolkit, currently in development- watch this space!

If you missed the presentation from Evan Cunningham, remember that it will be online to view within 24 hours #HCV #INHSU2021

Great to see our systematic review now published in The Lancet Gastroenterology & Hepatology on effective interventions to enhance #HCV care. Amazing leadership from Evan Cunningham Kirby Institute, UNSW in driving forward this massive effort. Thank you to our co-authors and those who contributed data.

A team of Kirby researchers have done an in-depth analysis, the largest of its kind, into the effectiveness of a range health interventions to improve hepatitis C care, identifying the best strategies to achieve elimination. Jason Grebely Evan Cunningham kirby.unsw.edu.au/news/what-heal…

Earlier this afternoon we held our 11th Brett Tindall Memorial Lecture with many thanks to A/Prof Behzad Hajari for presenting his interesting research on #hepC treatment uptake & the challenges to worldwide #hepC elimination. 👍Thanks to all who attended in-person and online.